HIV Drugs Market Size, Share & Industry Analysis, By Product Type (Integrase Inhibitors, Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Combination HIV Medicines, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI101115

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Epidemiology of HIV/AIDS, By Key Countries/Regions, 2025
2. Regulatory Scenario by Key Countries/Regions
3. Pipeline Analysis, By Key Players
4. Overview of Current Advances in R&D for HIV Drugs
5. Key Industry Developments – Mergers, Acquisitions, Partnerships etc.
6. New Product Launches, By Key Players
7. Impact of COVID-19 on the Market
Global HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Product Type
  2. Canada
    1. By Product Type
Europe HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
    1. By Product Type
  2. France
    1. By Product Type
  3. U.K.
    1. By Product Type
  4. Italy
    1. By Product Type
  5. Spain
    1. By Product Type
  6. Netherlands
    1. By Product Type
  7. Rest of Europe
    1. By Product Type
Asia Pacific HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
    1. By Product Type
  2. Japan
    1. By Product Type
  3. India
    1. By Product Type
  4. Australia
    1. By Product Type
  5. Southeast Asia
    1. By Product Type
  6. Rest of Asia Pacific
    1. By Product Type
Rest of the World HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. ViiV Healthcare
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Gilead Sciences, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. GlaxoSmithKline plc
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Merck & Co., Inc.,
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Bristol-Myers Squibb Company
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Boehringer Ingelheim International GmbH
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. AbbVie Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. F. Hoffmann-La Roche AG (Genentech, Inc.)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Mylan N.V.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Epidemiology of HIV/AIDS, By Key Countries/Regions, 2025
2. Regulatory Scenario by Key Countries/Regions
3. Pipeline Analysis, By Key Players
4. Overview of Current Advances in R&D for HIV Drugs
5. Key Industry Developments – Mergers, Acquisitions, Partnerships etc.
6. New Product Launches, By Key Players
7. Impact of COVID-19 on the Market
Global HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Product Type
  2. Canada
    1. By Product Type
Europe HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
    1. By Product Type
  2. France
    1. By Product Type
  3. U.K.
    1. By Product Type
  4. Italy
    1. By Product Type
  5. Spain
    1. By Product Type
  6. Netherlands
    1. By Product Type
  7. Rest of Europe
    1. By Product Type
Asia Pacific HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
    1. By Product Type
  2. Japan
    1. By Product Type
  3. India
    1. By Product Type
  4. Australia
    1. By Product Type
  5. Southeast Asia
    1. By Product Type
  6. Rest of Asia Pacific
    1. By Product Type
Rest of the World HIV Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Integrase Inhibitors
  2. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. Combination HIV Medicines
  4. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. ViiV Healthcare
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Gilead Sciences, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. GlaxoSmithKline plc
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Merck & Co., Inc.,
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Bristol-Myers Squibb Company
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Boehringer Ingelheim International GmbH
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. AbbVie Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. F. Hoffmann-La Roche AG (Genentech, Inc.)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Mylan N.V.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global HIV Drugs Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global HIV Drugs Market Value Share (%), By Product Type, 2025 & 2034

Figure 3: Global HIV Drugs Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 4: Global HIV Drugs Market Value (USD billion), by Region, 2025 & 2034

Figure 5: North America HIV Drugs Market Value (USD billion), By Product Type, 2025 & 2034

Figure 6: North America HIV Drugs Market Value Share (%), By Product Type, 2025

Figure 7: North America HIV Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 8: North America HIV Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 9: North America HIV Drugs Market Value (USD billion), By Country, 2025 & 2034

Figure 10: North America HIV Drugs Market Value Share (%), By Country, 2025

Figure 11: Europe HIV Drugs Market Value (USD billion), By Product Type, 2025 & 2034

Figure 12: Europe HIV Drugs Market Value Share (%), By Product Type, 2025

Figure 13: Europe HIV Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 14: Europe HIV Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 15: Europe HIV Drugs Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034

Figure 16: Europe HIV Drugs Market Value Share (%), By Country/ Sub-Region, 2025

Figure 17: Asia Pacific HIV Drugs Market Value (USD billion), By Product Type, 2025 & 2034

Figure 18: Asia Pacific HIV Drugs Market Value Share (%), By Product Type, 2025

Figure 19: Asia Pacific HIV Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 20: Asia Pacific HIV Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 21: Asia Pacific HIV Drugs Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034

Figure 22: Asia Pacific HIV Drugs Market Value Share (%), By Country/ Sub-Region, 2025

Figure 23: Rest of the World HIV Drugs Market Value (USD billion), By Product Type, 2025 & 2034

Figure 24: Rest of the World HIV Drugs Market Value Share (%), By Product Type, 2025

Figure 25: Rest of the World HIV Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 26: Rest of the World HIV Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 27: Global HIV Drugs Market Share (%), By Company, 2025

List of Tables

Table 1: Global HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 2: Global HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 3: Global HIV Drugs Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 4: North America HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021-2034

Table 5: North America HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 6: North America HIV Drugs Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 7: U.S. HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 8: Canada HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 9: Europe HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021-2034

Table 10: Europe HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 11: Europe HIV Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 12: Germany HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 13: France HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 14: U.K. HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 15: Italy HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 16: Spain HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 17: Netherlands HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 18: Rest of Europe HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 19: Asia Pacific HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021-2034

Table 20: Asia Pacific HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 21: Asia Pacific HIV Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 22: China HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 23: Japan HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 24: India HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 25: Australia HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 26: Southeast Asia HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 27: Rest of Asia Pacific HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 28: Rest of the World HIV Drugs Market Revenue (USD billion) Forecast, By Product Type, 2021-2034

Table 29: Rest of the World HIV Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 120

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com